Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/17845332

Download in:

View as

General Info

PMID
17845332